The SHAPE trial is the only phase III RCT so far. According to the results, simple hysterectomy was not superior to RH in early-stage, low-risk cervical cancer.
Simple hysterectomy may be considered a treatment option for stage IA2-IB1 disease.
If SLNB is available and SLNs are negative, systemic lymphadenectomy can be omitted (no further nodal dissection).
For SLNB, pathologic ultrastaging of SLNs is preferred to detect low-volume metastasis.
If SLN mapping fails, side-specific LND should be performed. Bulky nodes should be removed.